AACE 2021

Complete Coverage

Digital Therapeutics Platform Effective for Weight Loss, BMI Reduction

The use of a digital therapeutics platform in people with obesity and metabolic syndrome can lead to a reduction in both weight and body mass index (BMI), thereby reducing risk for comorbidities, according to study results presented at the 30th Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (ENVISION 2021). Digital…
Next post in AACE 2021